Company · founded 2008
Accelerated Medical Diagnostics (United States)
Davis, United States · acceleratedmeddiagnostics.com
- Citations, last 5 years
- 0
- Works, last 5 years
- 1
- h-index
- 16
- Scientists listed
- 0
- Grants since 2016
- 34
Grants received
2023–2025 · contract · N44
Proviral Sequencing Driven Development of Enhanced IPDAv2 with Global HIV-1 Group M Coverage to Support Worldwide Cure and Clinical Trials
Gregory Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2022–2024 · research · R43
Development of a novel fluorescent tracer for detection of retinal TDP43 in ALS and FTD
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2022–2027 · research · R44
Development of a topical tracer to detect TDP43 in ALS, LATE and FTD retinas for AI-powered disease insights
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2021–2023 · grant · American Jobs
Accelerate 500 Inc. 2021
Accelerated Medical Diagnostics (United States) · funded by Rockefeller Foundation
2021–2023 · research · R44
Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2021–2023 · research · R43
IPDA for High-Priority HIV-1 Subtype C to Enable Global Eradication Trials
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2021–2024 · grant · SB1
Development of an ophthalmic diagnostic probe for cerebral amyloid angiopathy in patients
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2021–2024 · research · R44
Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2021–2023 · grant · SB1
Development of an ophthalmic diagnostic probe for cerebral amyloid angiopathy in patients
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2021–2024 · research · R43
IPDA for High-Priority HIV-1 Subtype C to Enable Global Eradication Trials
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2021–2023 · research · R43
HIV-1 EnvLRS: a scalable, sequence-based assay for in-depth assessment of HIV-1 bNAb resistance
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2021–2023 · research · R43
Development of Novel Tau Retinal Tracers for Alzheimer's Disease and other Tauopathies
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2020–2021 · contract · N43
IPDA for High-Priority HIV-1 Subtypes to Enable Global Eradication Trials
Gregory Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2020–2023 · grant · American Jobs
Accelerate 500 Inc. 2020
Accelerated Medical Diagnostics (United States) · funded by Rockefeller Foundation
2020–2025 · cooperative agreement · U24
Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2020–2025 · cooperative agreement · U24
Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2020–2025 · cooperative agreement · U24
Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2020–2025 · cooperative agreement · U24
Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2020–2025 · cooperative agreement · U24
Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2020–2030 · research · R24
Centralized Resource to Accurately Quantify Latent and Expressed HIVReservoirs
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Development of Intact Proviral DNA Assays for SIV and SHIV
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Development of Novel Prion Disease Diagnostic
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2018–2021 · research · R43
Development of a quantitative assay for intact HIV DNA measures in tissue
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Highly specific HIV-1 mRNA detection method with global subtype coverage to monitor latency reversal in patients
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2017–2018 · research · R43
Development of a next-generation quantitative viral outgrowth assay (QVOA) for the standardized measurement of the HIV-1 latent reservoir
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Feasibility of predicting AML response to induction chemotherapy
Paul Thomas Henderson · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2017–2021 · research · R44
Development of a novel ophthalmic probe for cerebral amyloid angiopathy
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2017–2021 · research · R44
Development of a novel ophthalmic probe for cerebral amyloid angiopathy
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Development of a Novel Diagnostic Probe for Cerebral Amyloid Angiopathy
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2016–2021 · research · R44
A Novel Test to Measure Latent Virus in HIV-1 Infected Patients
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2016–2017 · research · R43
A Novel Test to Measure Latent Virus in HIV-1 Infected Patients
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2016–2019 · research · R44
A Novel Test to Measure Latent Virus in HIV-1 Infected Patients
Gregory Michael Laird · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2015–2025 · grant · SB1
Use of novel fluorescent tracers to develop a comprehensive retinal biomarker database that maps the heterogeneity of Alzheimer's pathogenesis
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health
2015–2025 · grant · SB1
Use of novel fluorescent tracers to develop a comprehensive retinal biomarker database that maps the heterogeneity of Alzheimer's pathogenesis
Stella Sarraf · Accelerated Medical Diagnostics (United States) · funded by National Institutes of Health